logo
logo

Modulus Discovery Closes $20.4M Usd Series C

Modulus Discovery Closes $20.4M Usd Series C

03/03/22, 2:00 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/JP.svgtokyo
Round Type
series c
Modulus Discovery, Inc., a preclinical-stage computation-driven drug discovery firm, announces the successful closing of its Series C funding round in the amount of 2.34B JPY (approximately $20.4M USD). Series C investors include Green Coinvest Investment Limited Partnership., SBI Group., Heights Capital Management, Inc., and existing shareholders including UTokyo Innovation Platform Co., Ltd., JAFCO Group Co., Ltd., Keio Innovation Initiative, Inc. (KII), and Fast Track Initiative, Inc. Modulus has raised to date, a total of 5.86B JPY (approximately $51M USD).

Company Info

Company
Modulus Discovery
Location
tokyo, tokyo, japan
Additional Info
In addition to accelerating its existing pipeline of over 10 R&D programs, the company aims to significantly increase its business value through expansion of its platform infrastructure, collaborations with industry and academic partners, and increase personnel in R&D and operations to deliver innovative drug candidates through clinical partnerships and additional drug discovery collaborations. The company is pursuing its proprietary portfolio of small-molecule discovery programs and collaborations through integration of its unique core biology insights, cutting-edge discovery platform, and scalable networked operations. We are so thrilled to be part of Modulus’ mission in the discovery of new medicines and treatments for more patients in need.”About Company;Modulus Discovery, Inc., is a preclinical-stage computation-driven drug discovery firm with offices in Tokyo and Boston.